Floatz logo

Human Relaxin 1

Atrial Fibrillation

Deeptankar DeMazumderprotein_peptidePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

20 Active assets in the Atrial Fibrillation cohort.

Asset / SponsorPhaseRating
Edoxaban
National Taiwan University Hospital
Phase 4A
Dabigatran
Pfizer
Phase 4BBB
Rivaroxaban
VA Office of Research and Development
Phase 4BBB
Warfarin
Pfizer
Phase 4BBB
Apixaban
Regeneron Pharmaceuticals
Phase 4BBB

View all 40 →

Same molecule, other indications

Human Relaxin 1 is also rated in:

systemic sclerosisDormant
B
Indicative · Phase 2
57 / 100
View asset →
cardiac rhythm diseaseActive
CCC
Indicative · Phase 1/2
48 / 100
View asset →
cardiovascular disorderActive
CCC
Indicative · Phase 1/2
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →